BEEDIMANI, R. S.; KALMATH, B. Canagliflozin: a novel ‘glucuretic’ approach for the treatment of type 2 diabetes mellitus. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 3, n. 3, p. 578–580, 2017. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/1032. Acesso em: 29 sep. 2025.